Studies Show More Promising Results for RSV Drug Nirsevimab

• 2024

  Log in to bookmark this resource.

  Log in
• Stephanie Soucheray

---

Access Resources

• SummaryEN
• Ask aRCie About This Resource

About

This blog post describes two studies showing that the RSV drug nirsevimab is effective in protecting infants from respiratory syncytial virus. The first study found that nirsevimab reduced RSV infections without increasing other viral infections. In a trial, 24 cases of RSV were reported in the treatment group compared to 54 in the placebo group. The second study showed many New York City infants received nirsevimab within their first week of life, following health guidelines. Ensuring enough supply for future seasons is important to protect young children from severe illness caused by RSV.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stages: Response; Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Double-Blind Method; Enterovirus Infections; Infant, Newborn; Placebos; Respiratory Syncytial Virus Infections; Clinical Trials, Phase III as Topic

Institutions: University of Minnesota

---

More like this

Estimates: Nirsevimab 89% Effective Against RSV in Kids, 93% Against Hospitalization 2024 · University of Minnesota Extending the Reach of Pediatric Emergency Preparedness: A Virtual Tabletop Exercise Targeting Children’s Needs 2019 · Centers for Disease Control and Prevention (CDC), University of Minnesota, University of Southern California Surge Capacity Principles: Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement 2014 · University of Minnesota, The Hebrew University of Jerusalem, George Washington University, University of British Columbia, Sharp Healthcare, Allina Health Care

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---